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Iodineis a necessary element forthe production of thyroid hormone.Wewill review the impact of dietary iodinestatus on thyroid
function in pregnancy. We will discuss iodine metabolism, homeostasis,and nutritional recommendations for pregnancy. We will
also discuss the possible eﬀects of environmental contaminantson iodine utilization in pregnant women.
1.Iodine HomeostasisinPregnancy
1.1. Iodine Absorption and Metabolism. Iodine, consumed in
food, water, or supplements, is absorbed by the stomach and
duodenum (97%) [1]. Its only known use in the human
body is in the production of thyroid hormone. Uptake of
iodine by the thyroid varies with intake. When iodine intake
is suﬃcient, the proportion cleared from the blood by the
thyroid ranges from 10% to 80% of absorbed iodine [1]. The
active transport of iodine from the blood into the thyroid
is regulated by thyroid-stimulating hormone (TSH) from
the pituitary gland and by the concentration of iodine in
the blood. This active transport is mediated by the sodium-
iodine symporter (NIS), a protein present on the basolateral
surface of the thyroid epithelial cell [1]. Iodine entering
the thyroid is oxidized to form “active” iodine which then
iodinates tyrosine to form monoiodotyrosine (MIT) and
diiodotyrosine(DIT).ThecouplingofMITandDITthrough
an ether linkage generates the thyroid hormones, thyroxine
(T4)and triiodothyronine (T3),which are thencleavedfrom
thyroglobulin, pass through the golgi, and are secreted into
the peripheral circulation. All of the steps directed toward
the generation of T4 and T3 are stimulated by thyroid
peroxidase (TPO) (Figure 1). The half-lives of T4 and T3
in the circulation are approximately one day for T3 and
seven days for T4. Peripheral deiodinases further metabolize
thyroid hormone and add to circulating iodine (Figure 2). In
particular, deiodinase 2 (D2) is responsible for the majority
of extrathyroidal T3 production by cleaving iodide from the
51 position. The iodine that is cleaved from T4 and T3 re-
enters the circulation where it is available for reutilization by
the thyroid. Iodine that is not actively transported into the
thyroid is primarily excreted in the urine (90%) with a very
small amount present in the feces [1].
1.2. Physiologic Changes in Pregnancy. Pregnancy induces
several major changes to thyroid physiology. The ﬁrst is
i n c r e a s e dd e m a n do nt h em a t e r n a lt h y r o i dg l a n d .T 4p r o -
duction increases approximately 50% starting in early preg-
nancy. High levels of circulating estrogen during pregnancy
decrease catabolism of the sialic acid-rich thyroxine-binding
globulin (TBG) [2]. Consequently, circulating TBG levels
increase 1.5-fold, increasing the levels of circulating total
T3 and T4 and requiring an increase in thyroid hormone
production to maintain normal unbound thyroid hormone
levels. Additionally, in early gestation, the thyroid is stim-
ulated not only by TSH but by the alpha subunit of
human chorionic gonadotropin (hCG), which also binds to
and stimulates the TSH receptor [3]. hCG is produced by
the syncytiotrophoblasts of the developing pregnancy. Its
production begins in the ﬁrst days of pregnancy and peaks
at 9–11 weeks of gestational age. Levels then decline until
approximately 20 weeks of gestation and remain stable for
the remainder of the pregnancy [3]. Finally, the placenta is2 Journal of Thyroid Research
NIS
T3
T4
Peripheral circulation
Thyroid follicular lumen
2Na+
2Na+
Hydrolysis
MIT DIT
I-
I-
I-
I-
I- I-
Tg Tg Tg
Figure 1: Thyroid hormone synthesis. NIS: Sodium-iodide sym-
porter; T4: Thyroxine; T3: Triiodothyronine; MIT: Monoiodothy-
ronine; DIT: Diiodothyronine; Tg: Thyroglobulin (I−:i o d i n a t e d ) .
an active site for the inner ring deiodination of T4 and T3,
generating the inactive iodothyronines, reverse T3 and 3,
31-T2, respectively, presumably as a means of modulating
the amount of active hormone that passes to the fetus [4].
(Figure 2) These processes all contribute to the increase in
thyroid hormone requirement during pregnancy.
Increased thyroid hormone production in pregnancy
requires adequate iodine availability. In iodine-replete
regions, women typically begin pregnancy with 10–20mg of
iodine stored in the thyroid and, with continued suﬃcient
iodine ingestion, are able to meet the increased demands
of pregnancy. However, urinary iodine concentration (UIC),
a reﬂection of iodine status, declines across pregnancy in
women from iodine-deﬁcient regions who may begin preg-
nancy with inadequate intrathyroidal iodine stores which are
rapidly depleted [2]. If adequate iodine is not available, TSH
rises and consequently goiter develops [2].
Another reason for increased iodine requirements in
pregnancy is the increase in maternal glomerular ﬁltration
rate. Because iodine is passively excreted, increased renal
glomerular ﬁltration results in increased losses of ingested
iodine [5].
The fetus and placenta also consume a proportion of
maternal thyroid hormone and iodine. Fetal thyroidogenesis
occurs by approximately the twelfth week of gestation. The
fetal thyroid is capable of organifying iodine by approxi-
mately the 20th week of gestation. Before this time, maternal
T4—the only form of thyroid hormone that can traverse
the placenta in small amounts—must be adequate to meet
the metabolic needs of the fetus. Fetal deiodinase converts
maternal T4 to the bioactive T3 [6]. Once fetal thyroid gland
function is established, fetal thyroidal turnover of iodine
is much higher than adult [7]. Therefore, the fetal iodine
store—supported exclusively by maternal intake—must be
continuously refreshed.
I o d i n eh o m e o s t a s i sv a r i e sa c r o s st h et h r e et r i m e s t e r sa s
metabolic needs ﬂuctuate.After parturition, maternal iodine
continues to be the only source of iodine to the breast-fed
neonate. NIS is present in breast tissue and is responsible for
concentrating iodine in colostrum and breast milk [8].
2.Effectsof IodineDeﬁciency
2.1. Eﬀects of Severe Iodine Deﬁciency. Severe dietary mater-
nal iodine deﬁciency in pregnancy has the potential to
cause both maternal and fetal hypothyroidism. Severeiodine
deﬁciency isassociated with poorobstetric outcomesinclud-
ing spontaneous abortion, prematurity, and stillbirth [9].
Thyroid hormone plays an essential role in neuronal migra-
tion, myelination, and synaptic transmission and plasticity
[6, 10]. Animal models have demonstrated that even mild
and transient maternal hypothyroxinemia during pregnancy
can disrupt neuronal migration in the fetus, resulting in
ectopic neurons in diﬀerent cortical layers including the
subcortical white matter and hippocampus [11]. Therefore,
iodine deﬁciency is associated with adverse eﬀects on the
fetus including congenital anomalies, decreased intelligence,
and neurological cretinism (which includes spasticity, deaf
mutism, mental deﬁciency, and squint) [9]. Despite global
public health eﬀorts, iodine deﬁciency remains the lead-
ing preventable cause of mental retardation worldwide
[12]. Severe iodine deﬁciency is also linked to intellectual
development in early childhood in the absence of overt
mental retardation. A 2005 meta-analysis of Chinese studies
comparing intelligence quotient (IQ) of children living in
naturally iodine-suﬃcient areas to children living in severely
iodine deﬁcient areas found that the IQ of iodine-suﬃcient
children, on average, was 12.45 points higher [13].
2.2. Eﬀects of Mild-to-Moderate Iodine Deﬁciency. The eﬀects
of mild-to-moderate iodine deﬁciency are less well under-
stood than those of severe iodine deﬁciency. Hypothe-
ses regarding the neurodevelopmental impact of mild-to-
moderate maternal iodine deﬁciency are extrapolated from
studies that examine the neonatal impact of mild maternal
thyroid hypofunction on oﬀs p r i n g .P o pe ta l .e x a m i n e d
Bayley Scales of Infant Development scores among 10-
month-old infants of women with fT4 levels below the tenth
percentile in the ﬁrst trimester of pregnancy compared to
infants of women with higher fT4 levels at that gestational
age [14]. The infants with lower maternal fT4 had signif-
icantly lower psychomotor scores. Henrich et al. studied
expressive vocabulary at the age of 18 and 30 months in
3659 children of women with normal TSH but varying fT4
[15].TheyfoundthatlowermaternalfT4wasassociatedwith
an increased risk of expressive language delay. Haddow et
al. assessed the IQ of 7- to 9-year-old children of women
with subclinical hypothyroidism in pregnancy, identiﬁed
by elevated TSH in the second trimester, and found that
IQ scores in these children averaged 7 points lower than
children of matched women with normal thyroid functionJournal of Thyroid Research 3
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Figure 2: Thyroid hormone metabolism. D1: Type 1 deiodinase; D2: Type 2 deiodinase; D3: Type 3 deiodinase.
in the second trimester [16]. All of these studies underscore
the impact of even mild thyroid hypofunction on fetal
neurodevelopment. However, because they were conducted
in iodine-suﬃcient areas, thus the thyroid hypofunction
cannot be directly attributed to iodine deﬁciency.
A small study found a signiﬁcantly greater prevalence
of attention deﬁcit hyperactivity disorder (ADHD) among
the oﬀspring of mothers from an area of mild-to-moderate
iodine deﬁciency in comparison to those of mothers in
a “marginally” iodine-suﬃcient area [17]. Vermiglio et al.
followed these children over ten years, ultimately diagnosing
68.7% of the children from iodine-deﬁcient areas with
ADHD. In contrast, none of the children from the iodine-
suﬃcient area were diagnosed with ADHD. 63.6% of the
children diagnosed with ADHD were born to the mothers
of the iodine-deﬁcient area who were known to have been
hypothyroxinemic early in gestation.
3.Assessment ofIodine Status
The World Health Organization (WHO)/International
Council for the Control of Iodine Deﬁciency Disor-
ders/UnitedNationsChildren’s Fund(UNICEF)recommend
median UIC as the primary tool for assessment of iodine
status in pregnant populations [9]. This can be measured
either over 24 hours or as a spot collection and can be
expressed as mcg per liter or per gram creatinine. Because
UIC is highly inﬂuenced by recent iodine intake, it can only
be used to determine iodine status for populations, not for
individuals [18]. Optimal median urinary iodine parameters
are higher in pregnancy than the median values of 100–
199mcg/L consistent with iodine suﬃciency in nonpregnant
populations (Table 1).
Table 1: World Health Organization optimal median urinary
iodine concentration values for populations [9].
Iodine suﬃcient population Median UIC
Nonpregnant adult 100–199mcg/L
Pregnant women 150–249mcg/L
Lactating women ≥100mcg/L
4.Iodine NutritioninPregnancy
4.1. Recommended Daily Intake. WHO recommends inges-
tion of approximately 250mcg iodine daily for pregnant
and lactating women [9]. The United States Institute of
Medicine’s recommended daily allowance for iodine is
220mcg during pregnancy and 290mcg during lactation
[20]. The American Thyroid Association (ATA) strongly
advocates adequate daily iodine intake in pregnancy, specif-
ically recommending that women in North America take
150mcg of iodine daily as a potassium iodide supplement
during pregnancy and lactation in order to attain adequate
levels [19]( Table 2).
4.2. Achieving Iodine Suﬃciency. In many regions, the rec-
ommended iodine intake may be met by diet alone. Iodine
e n t e r st h ed i e ti nm u l t i p l ef o r m s .I ns o m er e g i o n s ,i o d i n ei s
also present in drinking water. Worldwide, salt iodization is
an ongoing eﬀort springing from the recognition in the 20th
century that inexpensive spraying of commercial salt with
iodide can reverse iodine deﬁciency disorders [21]. In the
USA women are exposed to iodine not only through iodized
salt but also in other foods. Milk, yogurt, and other dairy
products contain iodine as a result of the use of iodophor
cleansers in the dairy industry and iodine supplementation4 Journal of Thyroid Research
Table 2: World Health Organization (WHO) and Institute of Medicine (IOM) recommendations for dietary iodine intake [10, 19].
WHO-recommended daily iodine intake IOM-recommended daily iodineintake
Adequate intake for nonpregnant adult 150mcg 150mcg
Adequate intake in pregnant women 250mcg 220mcg
Adequate intake for lactating women 250mcg 290mcg
of cattle feed [22]. Some USA commercial breads contain
high levels of iodine as well due to the use of iodate
conditioners [23]. The most recent Total Diet Study by the
U.S. Food and Drug Administration supports these two food
groups as the main nonsalt sources for iodine in the U.S.
[24]. In a market basket analysis, the average daily iodine
intake among USA adults was calculated to be adequate at
138–353mcg per person [24].
Despite ongoing availability of iodine in the diet and
salt in the United States, National Health and Nutrition
Examination Survey (NHANES) data demonstrates that
the overall USA iodine intake has decreased over the past
forty years from a median urinary iodine concentration of
320mcg/L in 1970 to 160mcg/L in 2003 [25]. The overall
medianUICamongpregnantwomenintheUSAthroughout
from 2001 to 2006 was marginal at 153mcg/L. NHANES
2005–2008 demonstrated that 35.3% of U.S. women of
reproductive age had UIC < 100mcg/L [25]. In the U.S.,
there is a higher prevalence of mild iodine deﬁciency in
the pregnant population compared to the general popu-
lation. The proportion of pregnant and reproductive aged
nonpregnant women with UIC < 50mcg/L has increased
from 4% to 15% over the past 40 years, as documented by
serial NHANES analyses [26]. These data suggest that in the
U.S. an increasing proportion of this vulnerable population
may be at risk for iodine deﬁciency. Worldwide, iodine
deﬁciencyremains an important publichealthproblem,with
an estimated 31% of the world’s population still living in
iodine-deﬁcient regions [9].
4.3. Iodine Supplementation. If dietary iodine intake is
insuﬃcient, then supplementation is necessary. However,
adequate supplementation is not currently easily achievable
in the USA. A recent survey of all U.S. prescription
and nonprescription prenatal vitamins revealed that only
approximately 50% contained any iodine [27]. In prenatal
multivitamins in which iodine was provided in the form of
kelp, the amount of daily iodine was dramatically variable,
making kelp an unreliable source for supplementation [27].
Among prenatal vitamins containing iodine in the form
of potassium iodide, measured iodine levels were more
reliable. However, when 150mcg potassium iodide was listed
as an ingredient, 23% of the mass was attributable to
the potassium, thus providing only on average 119mcg
daily dose of iodide, lower than the 150mcg daily dose
recommended by the ATA. Worldwide, strategies to meet the
iodine requirements set forth by WHO vary by region and
local dietary intake [28].
4.4. Risks of Iodine Excess. There is controversy regarding
the upper limit of acceptable iodine intake in pregnancy.
When iodine is present in great excess, the iodination of thy-
roglobulin is acutely inhibited via the acute Wolﬀ-Chaikoﬀ
eﬀect [29]. The mechanism is not well understood but is
believed to involve newly formed iodolipids or iodolactones
temporarily inhibiting thyroid peroxidase synthesis. After a
few days, the thyroid is able to “escape” from the acute
Wolﬀ-Chaikoﬀ eﬀect, in part by downregulating NIS on the
basolateral membrane and thereby modulating the inﬂux
of iodine entering into the thyroid [30]. The fetal thyroid
gland does not acquire the capacity to escape from the
acute Wolﬀ-Chaikoﬀ eﬀect until approximately 36 weeks
gestation [31]. Therefore, a maternal iodine load could
potentially cause fetal, but not maternal, hypothyroidism.
The Institute of Medicine recommends an upper limit of
1,100mcg dietary iodine daily in pregnancy, while WHO
recommends an upper limit of 500mcg per day [9, 20].
The beneﬁts of correcting iodine deﬁciency far outweigh
the risks of supplementation as long as supplementation
is not excessive [32]. Studies have demonstrated increased
umbilical cord and fetal TSH in study groups given iodine
supplementation. None, however, have demonstrated poor
outcome among these neonates, and in contrast, two studies
have demonstrated improved neurocognitive outcomes in
these groups [33, 34].
5.Impact of Iodine Supplementationin
Deﬁcient Populations
5.1. Impact on Maternal Thyroid Function. Studies assessing
the impact of iodine supplementation in mildly to mod-
erately iodine-deﬁcient women have had variable results
with regard to maternal thyroid function. However, sup-
plementation of iodine in this population appears overall
safe. Romano et al. found increased thyroid size in 17
pregnant women receiving daily iodine supplementation
in the form of 120–180mcg iodized salt compared to 18
women who were not supplemented [35]. Pedersen et al.
randomly assigned 47 iodine-deﬁcient pregnant women to
start either 200mcg daily potassium iodide or placebo
at 17–18 weeks of gestation [36]. The untreated group
not only had increased thyroid volume but also increased
maternal and cord blood thyroglobulin and maternal TSH.
No diﬀerence was found in maternal or cord blood thyroid
hormone levels. In contrast, Antonangeli et al. found no
signiﬁcant diﬀerences in maternal TSH, thyroid hormone,
thyroglobulin, or thyroid volume in 67 pregnant women
randomly assigned to 50mcg or 200mcg iodide daily as
compared to controls [37]. Liesenk¨ otter et al. similarly
found no diﬀerence in maternal thyroid volume in 38
pregnant women supplemented with 300mcg of iodine daily
compared to controls and no diﬀerence in thyroid functionJournal of Thyroid Research 5
t e s t i n go fm o t h e ro rn e o n a t e[ 38]. Nohr and Laurberg found
increased cord blood TSH in neonates from 49 mothers
supplemented with a daily multivitamin that contained
150mcg iodine compared with controls [39]. However, fT4
was slightly higher in the neonates of treated versus control
mothers.While theresultsregarding impactonmaternal and
fetal thyroid function are variable, none of these early studies
addressed neurocognitive outcomes in the oﬀspring.
5.2. Iodine Supplementation in Severe Deﬁciency: Eﬀects
on Oﬀspring. The ﬁrst study to demonstrate that iodine
supplementation in severe iodine deﬁciency signiﬁcantly
decreases the risk of cretinism was performed in the 1970s
[40].Severelyiodine-deﬁcient womeninPapua NewGuinea,
regardless ofpregnancy status,were giveniodine supplemen-
tation.The oﬀspring from the treated group had no evidence
of cretinism, while 6% of infants born to untreated mothers
had cretinism. Subsequent studies were conducted in Zaire,
China, Peru, and Ecuador, areas known to be severely
iodine deﬁcient. All four studies demonstrated varying but
consistently improved cognitive scores for children whose
mothers received iodine supplementation during pregnancy
[41–44].
5.3. Iodine Supplementation in Mild to Moderate Iodine
Deﬁciency: Eﬀects on Oﬀspring. Recently, two studies have
identiﬁed improved neurologic outcomes in the infants of
mildly to moderately iodine-deﬁcient women who received
iodine supplementation early in gestation. Velasco et al.
supplemented 133 pregnant women with 300mcg of iodine
daily during the ﬁrst trimester of pregnancy and examined
psychological development of the oﬀspring at the age of
3–18 months compared to oﬀspring of a group of 61
control women [33]. Upon initiation of supplementation,
the treatment groups had adequate mean UICs of 153mcg/L
and 213mcg/L among women initiated at less than and
more than 10 weeks of gestation, respectively, both ade-
quate according to WHO criteria. However, by the third
trimester, signiﬁcant diﬀerences were seen in the UICs of
the treatment versus control groups. Treated women had
a mean UIC of 203mcg/L, while the control group’s
mean value was 87mcg/L, consistent with mild-to-moderate
iodine deﬁciency. Psychomotor assessment at 3–18 months
was signiﬁcantly higher in the oﬀspring of the treated group.
Within this group, psychomotor scores were also noted to be
higherinoﬀspringofwomenwhose serumfT4measurement
remained stable throughout pregnancy in comparison to
those whose fT4 declined.
Berbel et al. examined the eﬀects of a 200mcg daily
iodine supplement in mildly to moderately iodine-deﬁcient
Spanish pregnant women [34]. Women were divided into
three groups, one of which started iodine supplementation
at 4–6 weeks of gestation, the second at 12–14 weeks,
and the third only in the postpartum period. Consistent
with prior studies, neurocognitive scores were signiﬁcantly
higher in groups who received iodine supplementation
during pregnancy when compared to women who did not
start until postpartum. Importantly, neurocognitive scores
were also signiﬁcantly higher in the group who initiated
iodine supplementation at 4–6 weeks of gestational age,
during organogenesis, in comparison to those who began
supplementation at 12–14 weeks of gestational age.
The eﬀect of iodine supplementation on ADHD risk has
not been studied.
6.Impact of EnvironmentalPollutants
Women with inadequate iodine nutrition in pregnancy may
be particularly vulnerable to the eﬀects of environmental
thyroid disruptors. At pharmacologic doses, several environ-
mental contaminants can aﬀe c ti o d i n eu p t a k ea tt h et h y r o i d
and subsequent thyroid function. Exposures to low-dose
perchlorate, thiocyanate, and nitrate are all ubiquitousin the
United States. All three substances are competitive inhibitors
of the sodium-iodine symporter (NIS) [45].
6.1. Perchlorate. Perchlorate is the most potent of the
environmental NIS inhibitors, exhibiting roughly 30 times
the aﬃnity for NIS than iodine [46]. It is a byproduct of
the manufacture of solid propellants used in rocket fuel.
It has also been found in Chilean nitrate fertilizers used
around the world. In the U.S., it is ingested in foods such
as lettuce, wheat, and dairy and is detectable in low levels
in groundwater in some regions [45]. Studies of perchlorate
levels in infant formula found low levels in brands of U.S.
formula tested [47, 48]. Perchlorate is remarkably stable
not only in the environment but also in the human body,
and thus exposure may be reliably assessed using urine
concentrations. In vitro studies have demonstrated that
at pharmacologic doses perchlorate decreases the active
transport of iodine into tissue. There has been concern
that low-level environmental exposure to NIS inhibitors
could decrease iodine intake into the thyroid causing thyroid
dysfunction and could also decrease NIS-mediated uptake
of iodine into breast milk. The oﬀspring of pregnant and
lactatingwomenwouldpotentiallybeathighestriskforthese
eﬀects [46].
The clinical impact of low-level environmental perchlo-
rate on thyroid status in vulnerable populations remains
unclear. An NHANES 2001-2002 analysis detected low levels
of perchlorate in all urine samples (n = 2820) collected
[49]. This large-scale study also demonstrated an inverse
correlation between perchlorate and total T4 and a positive
correlation with TSH in women but not men. This relation-
ship was stronger among women with a UIC of < 100mcg/L
[50]. This eﬀect on thyroid function has not been replicated
in other studies. Several prospective studies administering
increasing amounts of perchlorate tohealthy human subjects
have failed to demonstrate analogous changes in thyroid
function other than a decrease in thyroidal iodine uptake
at the highest doses [51–53]. Another cross-sectional study
of environmental perchlorate exposure failed to ﬁnd any
association with ﬁrst trimester thyroid function among 1600
iodine-deﬁcient pregnant women [54]. While perchlorate
has been identiﬁed in breast milk and colostrum in several
small studies, there are no data yet to suggest that neonatal6 Journal of Thyroid Research
consumption via breast feeding compromises the iodine
status of the infant [47, 55].
6.2. Other NIS Inhibitors. Thiocyanate is a less potent com-
petitiveinhibitoroftheNIS.Itisametabolite ofcyanidepro-
duced from cigarette smoke and is found in various foods.
Decreased T4, increased TSH, and thyroid enlargement
have been reported among pregnant women who smoke
[56]. Another study showed an association between cigarette
smoking and decreased breast milk iodine concentration
[57]. While compared to thiocyanate, perchlorate has 15
times the aﬃnity for the NIS, the cumulative eﬀects of one
or both may still pose a risk to vulnerable populations.
Nitrate has a signiﬁcantly lower aﬃnity for NIS than
eitherperchlorate or thiocyanate. However, it is omnipresent
as a by-product of decomposition of organic materials. It is
present in soil and groundwater and is found in virtually
all crops, particularly root vegetables. Sodium nitrite is also
used as a food preservative. The average daily adult intake of
nitrate per day in the U.S. is 75–100mg daily. Several recent
studies from Bulgaria and Slovakia suggest an increased
risk of goiter and subclinical hypothyroidism in iodine-
suﬃcient areas with chronic exposure to very high nitrate
concentrations. Small studies undertaken in the U.S. have
failed to demonstrate the same association [45].
While the independent eﬀect of these individual con-
taminants on iodine utilization and thyroid function may
be small, it remains to be seen whether their cumulative
exposure together with the national trend toward decreasing
iodine intake among reproductive aged women in the U.S.
may have adverse eﬀects on thyroid function.
7.Conclusions
Women who are pregnant or lactating have increased
dietary iodine requirements. Severe iodine deﬁciency leads
to adverse maternal and fetal consequences. Even mild-to-
moderate iodine deﬁciency in pregnancy has adverse eﬀects
on obstetric and neonatal outcomes. Recent data on the
neonatal neurocognitive impact of early iodine supplemen-
tation suggests that adequate iodine intake should start as
soon as the patient is aware she is pregnant, or, even better,
should be incorporated as part of preconception planning.
Research is needed on the impact of iodine supplementation
in lactating women and their infants. Providers who care
for pregnant women are encouraged to be aware of this
essential micronutrient and counsel adequate iodine intake
throughout preconception, pregnancy, and lactation.
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